EIA campaigners will be in Vienna from Monday for the week-long 35th session of the UN Commission on Crime Prevention and Criminal Justice (CCPCJ). The meeting comes at a critical time for international efforts to address crimes that affect the environment, an area where political attention is increasing but collective action still falls short of […]
With approximately just 5,500 wild tigers left in the world, this iconic species remains under threat from a variety of factors, particular illegal wildlife trade. The illegal trade in tigers and their parts and derivatives continues to be fuelled by facilities holding tigers in captivity, especially in China. One survey estimated more than 6,000 individual […]
Covering one packed agenda, four interventions and six hectic days, EIA campaigners share the highlights of the 78th meeting of the Standing Committee (SC78) of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) in Geneva. Elephants Asian elephants SC78 marked EIA’s first engagement at CITES on the […]
This year is a big one for the Convention on International Trade in Endangered Species (CITES), with the 78th meeting of the Standing Committee (SC78) kicking off in Geneva, Switzerland from 3-8 February. This will be followed by the much larger 20th Conference of the Parties (CoP20) in Samarkand, Uzbekistan later in the year. EIA […]
The Government of China has made a commitment (Chinese) to supporting the development of substitutes for endangered wildlife used in traditional Chinese medicine (TCM). The announcement by the National Medical Products Administration of China (NMPA) is an encouraging step towards ending the use of threatened wildlife in TCM and represents tangible progress following a proposal […]
Norges Bank has divested from a major traditional Chinese medicine (TCM) company in the wake of EIA’s major exposé Investing in Extinction, which found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 products. The bank cited an ‘unacceptable risk’ of Tianjin Pharmaceutical Da Re Tang Group Corp […]